Amcad Biomed (ROCO:4188) NonCurrent Deferred Liabilities : NT$0.00 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Amcad Biomed NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Amcad Biomed's non-current deferred liabilities for the quarter that ended in Mar. 2025 was NT$0.00 Mil.

Amcad Biomed NonCurrent Deferred Liabilities Historical Data

The historical data trend for Amcad Biomed's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amcad Biomed NonCurrent Deferred Liabilities Chart

Amcad Biomed Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

Amcad Biomed Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Amcad Biomed NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Amcad Biomed's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Amcad Biomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amcad Biomed Corp (ROCO:4188) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 167, Fuxing North Road, 5th Floor, Zhongshan District, Taipei, TWN, 104

Website

https://www.amcad.com.tw

Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. Geographically, the company generates revenue from Taiwan, China, Europe, Asia (excluding Taiwan and China), and other countries, out of which the majority of the revenue is generated from Taiwan. The company has two segments: the Medical Diagnostic Software segment, which is responsible for the development and sales of smart medical imaging diagnostic software devices, and the Precision Medical Equipment segment, which is responsible for research, development, manufacturing, and sales of high-end ultrasonic probes. The company generates the majority of its revenue from the Precision Medical Equipment segment.

Amcad Biomed Headlines

No Headlines